SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will provide attendees at the 16th annual Advances in Genome Biology and Technology (AGBT) meeting the first glimpse of PolarisTM, an integrated single-cell research system, in addition to other new products. This exciting new product is the first to integrate cell selection, isolation, dose, culture and molecular preparation into a single workflow, thereby enabling researchers to directly correlate gene expression with environmental conditions and phenotypic information.
With this new workflow, researchers will be able to conduct dose-response and time course studies on live, single cells to identify interesting genes that regulate critical pathways, as well as better evaluate the diversity of biological effects across cell types.
Help employers find you! Check out all the jobs and post your resume.
